FIELD: medicine.
SUBSTANCE: invention refers to medicine, namely to haematology, cardiology and endocrinology, and concerns normalisation of thrombocyte aggregation in patients suffering from arterial hypertension with impaired glucose tolerance. It is ensured by integrated treatment including graduated physical exercise, and introduction of pioglitazone in a dose 30 mg once a day in the morning and lisinopril in a dose 10 mg once a day in the morning during not less than 1.5 months.
EFFECT: such complex of specific medical products and physical exercise combined with empirically selected duration of treatment provides effective correction of thrombocyte aggregation and, thereby reduced risk of thrombotic complications in given group of patients.
1 ex
